Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of PEP/PrEP Via Pharmacist-Prescribing Implementation (PEPPI)

NCT07683117 is registered in ClinicalTrials.gov with EMPOWERX INC as lead sponsor.

NCT NCT07683117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07683117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of PEP/PrEP Via Pharmacist-Prescribing Implementation (PEPPI)
Lead sponsor
EMPOWERX INC
Phase
Not applicable
Overall status
Recruiting
Start date
August 31, 2026
Completion date
September 30, 2028
Enrollment
195 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

access and linkage to healthcare, hiv pre-exposure prophylaxis, hiv prevention, technology use